IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Ajooni Biotech IPO is a Fixed Price listing on NSE EMERGE exchange, with an ipo size of ₹ 6.59 Cr. The company is based in Mohali and caters to Agro sector. Navigant Corporate Advisors is the merchant banker of Ajooni Biotech IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 27th October 2017.
Ajooni Biotech IPO posted revenues of ₹ 33.46 crores and PAT of ₹ 0.38 crores in FY18 on annualised basis.
Revenue:
₹ 33.41 Cr.
EBITDA Margin:
3.88
% 
Net Worth: ₹ 4.10 Cr.
Market Capitalisation:
[●]
P/E:
45.00 times
P/BV: [●]
EV/EBITDA: [●]
Financial results of Ajooni Biotech IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Aug-17 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 15.64 | 12.85 | 2.42 | 1.61 | |
| Net Worth | 4.10 | 0.95 | 0.51 | 0.42 | |
| Total Debt | 5.23 | 5.05 | 0.77 | [●] | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
13.92
33.41 |
28.53 | 13.22 | 7.21 | |
EBITDA
EBITDA on annualised basis |
0.54
1.30 |
0.71 | 0.23 | 0.13 | |
PAT
PAT on annualised basis |
0.16
0.38 |
0.27 | 0.09 | 0.07 | |
Ajooni Biotech IPO PAT Margin is 1.15 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Ajooni Biotech IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Aug-17 | FY17 | FY16 | FY15 |
|---|---|---|---|---|
| EBITDA Margin (%) | 3.88 | 2.49 | 1.74 | 1.80 |
| PAT Margin (%) | 1.15 | 0.95 | 0.68 | 0.97 |
| EPS (₹) | 0.58 | 2.89 | 1.85 | 1.71 |
| ROE (%) | 3.90 | 28.42 | 17.65 | 16.67 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 1.02 | 2.10 | 3.72 | 4.35 |
| Debt to Equity | 1.28 | 5.32 | 1.51 | [●] |
The market Capitalisation of Ajooni Biotech IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Ajooni Biotech IPO prospectus highlights an Return on Equity (ROE) of 3.90 % , Return on Assets (ROA) of 1.02 %, and an EBITDA Margin of 3.88 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Ajooni Biotech IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Ajooni Biotech IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Ajooni Biotech IPO has a Price-to-Earnings (PE) ratio of 45.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Ajooni Biotech IPO reported revenue of ₹ 33.46 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Ajooni Biotech IPO provide insights into sales growth, market demand, and business scalability.
Ajooni Biotech recorded an EBITDA of ₹ 1.30 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Ajooni Biotech Profit After Tax (PAT) is ₹ 0.38 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 33.41 Cr.
EBITDA Margin:
3.88
%
Net Worth: ₹ 4.10 Cr.
Market Capitalisation:
[●]
P/E:
45.00 times
P/BV: [●]
EV/EBITDA: [●]
Ajooni Biotech operates in Agro and Manufacturing Of Cattle Feed. The Issue is listed on NSE EMERGE in Jan, 2018. Ajooni Biotech IPO size was 6.59 with Issue price of 30.00 .
Merchant Banker(s) of Ajooni Biotech IPO: Navigant Corporate Advisors Limited
Ajooni Biotech IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Ajooni Biotech IPO listed at a listing price of 36.00 against the offer price of 30.00.
The current market price of Ajooni Biotech is 6.03.
Why Us?
